The biomarker combination depicted offers the advantage of integrating different disease pathways and including at least one atrial-specific biomarker (BMP10), thus enabling differentiation for example between patients with AF and patients with heart failure23 or other conditions which may also elevate other cardiovascular biomarkers such as NTproBNP or TnT. The gene discussed is NPPB; the disease is atrial fibrillation.